Providing Families More Quality Time with their Companion Pets
Who We Are
The Harrington Oncology Program at the Tufts Foster Hospital for Small Animals at Cummings School of Veterinary Medicine provides state-of-the-art diagnostic, medical, radiation therapy and surgical techniques. Led by board-certified specialists in medical and radiation oncology, it is supported by a team of residents, dedicated technicians and staff.
Foster Hospital believes in a team approach to care and our oncologists work closely with a highly skilled surgery service with expertise in surgical oncology, as well as with the pathology, diagnostic imaging, interventional radiology and pain management services. Our collaboration allows us to offer treatment options that are customized based on the tumor type, the spread of the cancer, and the overall health of the pet. This could involve a single treatment modality or a combination of different therapies. In some cases, in accordance with the client’s wishes, a more conservative strategy may focus on palliative care. Through all of this we provide you and your client with detail on the type of cancer, treatment options, and expected outcomes, keeping quality of life as a top priority. The oncology service takes pride in ensuring that all of the client’s questions are answered and that the veterinarians, technicians and pet owners work as a team.
As an academic veterinary medical center, we are training the veterinarians of the future, and are also actively engaged in research into the causes, biology and treatment of cancer. As a member of the National Cancer Institute’s Comparative Oncology Trials Consortium, and through independent studies and collaboration with other veterinary and biomedical institutions, the oncology service is able to offer investigational therapies, in addition to conventional treatment. In addition, we participate in the Tufts Human Animal Cancer Collaborative with the Medical School at Tufts University, where treating cancer in companion animals helps inform how we treat humans.
Technology and Services Available
The Harrington Oncology Program is recognized nationally in the field, boasting some of the most advanced technology available in veterinary medical establishments. With medical staff and technicians well-versed and experienced in chemotherapy administration, radiation therapy and anesthesia, specific features of our service include:
- Intravenous, intralesional an intracavitary chemotherapy administration, including long continuous-rate infusions
- Melanoma vaccine administration
- Siemens Primus linear accelerator with 6MV photon and 6-21 MeV electron capabilities and a 56-leaf collimator that allows for intensity modulated radiation therapy
- Three-dimensional computerized radiation therapy planning
- Strontium plesiotherapy
- Various biospy techniques, including manual incision, punch, needle-core biopsies as well as image-guided (ultrasound or computed tomography) and open surgical procedures
- Interventional radiologic procedures, such as chemoembolization and intra-arterial chemotherapy administration
- Access to investigational clinical protocols
Referring a Patient
The Harrington Oncology Program typically sees new patients who have a confirmed cancer diagnosis. This often allows us to provide clients with a full array of staging and treatment options during the initial visit. We understand, however, that circumstances arise in which an oncology consult is valuable before a diagnosis is made. You should feel free to call us about these cases to facilitate a referral. We welcome the opportunity to even provide you with a telephone consult (free of charge) regarding general information on cancer management or to discuss a possible referral.
In situations when pet owners are uncertain whether they wish to pursue treatment for their pets with a cancer diagnosis, we encourage referrals to address their questions regarding anticipated course of the disease, treatment options and palliative care. You may contact Kelly Reed, our clinical liaison, at 508-887-4682, and she will facilitate all care for pets you refer.
Meet the Team
Radiation Oncology Faculty
Michele Keyerleber, DVM, DACVR, a board-certified veterinary radiation oncologist and faculty member, is a 2008 graduate of Cornell University’s College of Veterinary Medicine. She later completed a small animal internship at The Ohio State University, before returning to Cornell for a residency in radiation oncology. Dr. Keyerleber joined the faculty of Cummings School of Veterinary Medicine at Tufts University in 2011. Her research interests include radiation therapy planning for neoplasia in dogs and cats, brain tumors, and palliative radiation therapy. Dr. Keyerleber also has a strong interest in pain and side effect management for radiation therapy patients.
Elizabeth McNiel, DVM, PhD, DACVIM, DACVR is board-certified in radiation and medical oncology. She is a 1992 graduate of Texas A&M University and completed a small animal rotating internship at Angell Memorial Animal Hospital in Boston. Dr. McNiel completed a medical oncology residency program followed by a combined radiation oncology residency and PhD program at Colorado State University. Prior to coming to Cummings School of Veterinary Medicine at Tufts University in 2012, she served on the faculty of the University of Minnesota and Michigan State University. An active researcher, Dr. McNiel studies the molecular biology of canine and feline tumors in her laboratory at the Molecular Oncology Research Institute at the Tufts Medical Center. Her goal is to translate basic discoveries in the laboratory into clinical advances for animals through clinical trials.
Medical Oncology Faculty
Lisa Barber, DVM, DACVIM, is a 1992 graduate of Ohio State University. She completed a small animal internship and residency in veterinary oncology at the University of Pennsylvania School of Veterinary Medicine where she subsequently served as a staff oncologist prior to joining the faculty at Cummings School of Veterinary Medicine at Tufts University. She specializes in treating dogs and cats with a variety of cancers, and consults on large animals as well as exotic animals. Her research interests include epidemiologic studies to identify risk factors for various cancers as well as investigation of novel treatments for cancer.
Kristine Burgess, DVM, DACVIM, is a board-certified veterinary oncologist at the Tufts Foster Hospital for Small Animals at Cummings School of Veterinary Medicine. After receiving her undergraduate degree from UMass, and completing a masters degree from work at Dana-Farber Cancer Institute, Kristine went on to earn her DVM from the Cummings School in 1997. She subsequently completed her residency training at the University of Wisconsin. She collaborates with several other institutions to run clinical trials for new and advanced cancer treatments for dogs and cats, which may lead to better treatment options for both pets and humans.
Kelly Kezer, DVM, a first-year medical oncology resident, received her veterinary degree from Massey University in New Zealand. After graduation, she completed a small animal rotating internship at BluePearl Veterinary Partners in Tampa, Florida, a high-volume practice, where she solidified her interest in oncology. Dr. Kezer enjoys all aspects of veterinary oncology, but has particular interest in novel therapies and international veterinary medicine.
Felicia Lew, DVM, a second-year medical oncology resident, is originally from Seattle, Washington. A 2012 graduate of Washington State University College of Veterinary Medicine, she completed a small animal rotating internship at a private specialty hospital in San Diego, California. Dr. Lew has an interest in basic science research, specifically in cancer biology and carcinogenesis.
Bobbi McQuown, DVM, a third year oncology resident, is originally from the Midwest. Prior to veterinary school, she spent 5 years in the Army as a communications officer. In 2011, she graduated from the North Carolina State University College of Veterinary Medicine, subsequently completing a small animal rotating internship at VCA VREC/Shoreline in Connecticut. Her ongoing research includes assessment of palliative radiation therapy and anal sac tumors, IGF-1 levels in dogs with lymphoma, and the use of Palladia in dogs with heart base tumors.
Clinical Trials Coordinator